166 related articles for article (PubMed ID: 23817516)
41. Evidence-based guideline: clinical evaluation and treatment of transverse myelitis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Scott TF; Frohman EM; De Seze J; Gronseth GS; Weinshenker BG;
Neurology; 2011 Dec; 77(24):2128-34. PubMed ID: 22156988
[TBL] [Abstract][Full Text] [Related]
42. Lower motor neuron involvement in longitudinally extensive transverse myelitis with and without aquaporin-4 antibodies.
Luigetti M; Lo Monaco M; Evoli A; Mirabella M; Damato V; Iorio R
Clin Neurophysiol; 2014 Sep; 125(9):1925-6. PubMed ID: 24525092
[No Abstract] [Full Text] [Related]
43. The expanded spectrum of neuromyelitis optica: evidences for a new definition.
Lana-Peixoto MA; Callegaro D
Arq Neuropsiquiatr; 2012 Oct; 70(10):807-13. PubMed ID: 23060108
[TBL] [Abstract][Full Text] [Related]
44. NMO-IgG detected in CSF in seronegative neuromyelitis optica.
Klawiter EC; Alvarez E; Xu J; Paciorkowski AR; Zhu L; Parks BJ; Cross AH; Naismith RT
Neurology; 2009 Mar; 72(12):1101-3. PubMed ID: 19307546
[No Abstract] [Full Text] [Related]
45. [Diagnostic challenge in a man with intractable hiccups and vomiting: a case of neuromyelitis optica spectrum disorder (NMOSD)].
Kaloudi D; Svenningsson A; von Heijne A
Lakartidningen; 2019 Aug; 116():. PubMed ID: 31429915
[TBL] [Abstract][Full Text] [Related]
46. Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions.
Popescu BF; Guo Y; Jentoft ME; Parisi JE; Lennon VA; Pittock SJ; Weinshenker BG; Wingerchuk DM; Giannini C; Metz I; Brück W; Shuster EA; Carter J; Boyd CD; Clardy SL; Cohen BA; Lucchinetti CF
Neurology; 2015 Jan; 84(2):148-58. PubMed ID: 25503621
[TBL] [Abstract][Full Text] [Related]
47. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M;
J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675
[TBL] [Abstract][Full Text] [Related]
48. Longitudinally extensive transverse myelitis.
Tobin WO; Weinshenker BG; Lucchinetti CF
Curr Opin Neurol; 2014 Jun; 27(3):279-89. PubMed ID: 24792338
[TBL] [Abstract][Full Text] [Related]
49. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese.
Chan KH; Ramsden DB; Yu YL; Kwok KH; Chu AC; Ho PW; Kwan JS; Lee R; Lim E; Kung MH; Ho SL
Eur J Neurol; 2009 Mar; 16(3):310-6. PubMed ID: 19138340
[TBL] [Abstract][Full Text] [Related]
50. Very short multifocal myelitis lesions as initial signs of neuromyelitis optica spectrum disorder.
Seok JI; Park MS
Acta Neurol Belg; 2020 Oct; 120(5):1203-1205. PubMed ID: 31290015
[No Abstract] [Full Text] [Related]
51. Aquaporin-4-IgG positive neuromyelitis optica spectrum disorder and systemic autoimmune diseases overlap syndrome: a single-center experience.
Martín-Nares E; Hernandez-Molina G; Fragoso-Loyo H
Lupus; 2019 Oct; 28(11):1302-1311. PubMed ID: 31566079
[TBL] [Abstract][Full Text] [Related]
52. Longitudinally extensive transverse myelitis immune-mediated in aquaporin-4 antibody negative patients: Disease heterogeneity.
Carnero Contentti E; Hryb JP; Morales S; Gomez A; Chiganer E; Di Pace JL; Lessa C; Perassolo M
J Neurol Sci; 2017 Feb; 373():134-137. PubMed ID: 28131170
[TBL] [Abstract][Full Text] [Related]
53. Neuromyelitis optica.
Matiello M; Jacob A; Wingerchuk DM; Weinshenker BG
Curr Opin Neurol; 2007 Jun; 20(3):255-60. PubMed ID: 17495617
[TBL] [Abstract][Full Text] [Related]
54. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W
Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113
[TBL] [Abstract][Full Text] [Related]
55. MOG-IgG myelitis coexisting with systemic lupus erythematosus in the post-partum setting.
Bilodeau PA; Kumar V; Rodriguez AE; Li CT; Sanchez-Alvarez C; Thanarajasingam U; Zalewski NL; Flanagan EP
Mult Scler; 2020 Jul; 26(8):997-1000. PubMed ID: 31621483
[TBL] [Abstract][Full Text] [Related]
56. [Recurring neuromyelitis without optic neuritis: a case report].
Garcia-Rodriguez R; Fernandez-Dominguez J; Gomez-Illan R; Lopez-Roger R; Mateos V
Rev Neurol; 2012 Jul; 55(2):87-90. PubMed ID: 22760768
[TBL] [Abstract][Full Text] [Related]
57. Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays.
McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Hinson SR; Kryzer TJ; Lucchinetti CF; Weinshenker BG; Wingerchuk DM; Shuster EA; Pittock SJ
Arch Neurol; 2009 Sep; 66(9):1134-8. PubMed ID: 19752303
[TBL] [Abstract][Full Text] [Related]
58. Neuromyelitis optica in a young child with positive serum autoantibody.
Loma IP; Asato MR; Filipink RA; Alper G
Pediatr Neurol; 2008 Sep; 39(3):209-12. PubMed ID: 18725070
[TBL] [Abstract][Full Text] [Related]
59. [Neuromyelitis optica is a frequently seen inflammatory demyelinating disease].
Asgari N; Skejø HP; Lillevang ST; Stenager E
Ugeskr Laeger; 2013 May; 175(19):1331-5. PubMed ID: 23663369
[TBL] [Abstract][Full Text] [Related]
60. A case of longitudinally extensive transverse myelitis (LETM): neuromyelitis optica.
Mangat P; Ravindran J; Cleland L; Limaye V
Clin Rheumatol; 2008 Dec; 27 Suppl 2():S67-9. PubMed ID: 18560921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
